|
Intergroup phase III trial of neo-adjuvant chemotherapy, followed by chemoradiation and surgery with and without cetuximab in locally advanced esophageal carcinoma: First results from the SAKK 75/08 trial. |
|
|
|
Consulting or Advisory Role - AstraZeneca; Novartis; Roche |
Travel, Accommodations, Expenses - Amgen; Roche |
|
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; MSD; Nordic Bioscience; Pfizer; Roche |
Research Funding - Novartis (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Jorge Riera-Knorrenschild |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Celgene (Inst) |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche |
Expert Testimony - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche |
|
|
Honoraria - Amgen; Celgene; Lilly; Merck; Roche |
Consulting or Advisory Role - Amgen; Celgene; Lilly; Merck; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Nestlé health Science (Inst) |
Research Funding - Nestle Health Science (Inst) |
Travel, Accommodations, Expenses - Bard/Davol; Bard/Davol; Ethicon; Ethicon |
|
|
Travel, Accommodations, Expenses - CSL Behring (I) |
|
|
Stock and Other Ownership Interests - Amgen; Exelixis |
Consulting or Advisory Role - Fluentis (Inst); Impulse (Inst); Roche (Inst) |
Research Funding - Puma Biotechnology (Inst) |
Travel, Accommodations, Expenses - Bayer |
|
|
Consulting or Advisory Role - Bayer; Merck; Roche |
Speakers' Bureau - Celgene; Lilly; Taiho Pharmaceutical |
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen; Merck |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Ethicon; Medtronic |
|
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Celgene; Merck Serono; Roche |
Consulting or Advisory Role - Amgen; MSD; Sanofi; SERVIER |
Travel, Accommodations, Expenses - Amgen; Merck Serono; Sanofi |